Agilent Technologies Ultra-high-throughput fragment analysis 5400 Fragment Analyzer
Agilent Technologies Ultra-high-throughput fragment analysis 5400 Fragment Analyzer — Automated electrophoresis.
The Agilent 5400 Fragment Analyzer is a parallel capillary electrophoresis system built on the 5300 platform, configured for robotic integration and nine-plate capacity. It analyzes 96 samples simultaneously across a 2–6,000 nt sizing range with 3 bp separation resolution, distinguishing it from the three-plate 5200/5300 siblings. It serves high-throughput IVT mRNA and LNP-encapsulated drug substance/product quality control.
Agilent Technologies Fragment Analyzer Systems Series — Model Comparison & Selection
| Model | Measurement range | Plate capacity | Average sizing of 2 200 nt ivt mrna, nt | Lower marker size of hs rna kit, nt | Maximum ivt mrna sample size analyzed, nt | Sample volume per well, microliter |
|---|---|---|---|---|---|---|
| Ultra-high-throughput fragment analysis 5400 Fragment Analyzer Current | 0.5 | nine plates | 2370 | 15 | 6000 | — |
| 5200 Fragment Analyzer | — | — | 2370 | 15 | 6000 | 2 |
| 5300 Fragment Analyzer | — | — | 2370 | 15 | 6000 | — |
| Fragment Analyzer Capillary Arrays | — | 12 | — | — | — | 2 |
| RNA QC, DNA QC, Fragment Analyzer | — | 12 | — | — | — | 2 |
Full specifications
| Measurement range | 0.5 ng/µL |
| Average Sizing Of 2,200 Nt Ivt Mrna | 2370 nt |
| Lower Marker Size Of Hs Rna Kit | 15 nt |
| Maximum Ivt Mrna Sample Size Analyzed | 6000 nt |
| Plate capacity | nine plates |
| Separation resolution mfr | 3 bp |
| Dynamic range mfr | imately two orders of magnitude magnitude |
| Sizing range mfr | 35 bp |
| Sizing accuracy mfr | 5 |
| Sizing precision mfr | 2 |
| Sizing resolution mfr | 100 |
| Simultaneous sample analysis mfr | 96 samples |
| Sample types analyzed mfr | IVT mRNA drug substances and LNP-encapsulated IV |
| Additional sample mfr | 1 |
| Instrument mfr | 5300 system |
| LNP disruption mfr | varying amounts of surfactant surfactant |
| Surfactant levels tested mfr | 20 |
| Sample concentration range mfr | 1 ng/μL |
| Extended method mfr | Method BE BE |
| Dilution ratios tested mfr | 1 |
| IVT mRNA drug product sizes analyzed mfr | 2,200 nt |
| Surfactant concentrations tested for LNP disruption mfr | 20 |
| Sample concentration range assessed mfr | 1 ng/μL |
| Dilution ratios assessed with extended method mfr | 1 |
| upper marker size mfr | 1500 bp |
| upper marker size (ZAG 110/915 kits) mfr | 5000 bp |
| initial denaturation time mfr | 30 seconds |
| denaturation time mfr | 10 seconds |
| annealing time mfr | 30 seconds |
| extension time mfr | 15...30 kilobase |
| number of PCR cycles mfr | 30 cycles |
| final extension time mfr | 10 minutes |
| disruption time mfr | 20 minutes |
| sizing accuracy specification mfr | 15 % error |
| sizing precision specification mfr | 5 % CV |
| Weight | 38.5 kg |
| Sample sizes (nucleotide length) mfr | 2,200 nt |
| capillary array effective length (ultrashort) mfr | 22 cm |
| capillary array total length (ultrashort) mfr | 47 cm |
| capillary array effective length (short) mfr | 33 cm |
| capillary array total length (short) mfr | 55 cm |
| capillary array effective length (long) mfr | 55 cm |
| capillary array total length (long) mfr | 80 cm |
| standard sizing upper limit mfr | 6000 nt |
Description
Construction and series positioning
- The 5400 is a parallel capillary electrophoresis instrument derived from the 5300 Fragment Analyzer platform and accepts the same reagent kits, but adds robotic-integration compatibility and a nine-plate deck versus the three-plate capacity of the standard Fragment Analyzer.
- It is the ultra-high-throughput modification of the series; the 5200 and 5300 are lower-capacity siblings, and the 5300 is quoted at 5 pg/µL sensitivity.
- Simultaneous analysis of 96 samples per run; instrument weight 38.5 kg.
Analytical behavior
- Sizing range spans 2 to 6,000 nt, with 3 bp separation resolution and a dynamic range of approximately two orders of magnitude.
- Sizing accuracy and precision are stated as 5 and 2 respectively (unitless in the source), and sizing resolution as 100.
- Documented application data cover IVT mRNA drug substances and LNP-encapsulated IVT mRNA drug products at 2,200, 9,400 and 11,000 nt, including Fluc mRNA-LNP; average sizing of a 2–200 nt IVT mRNA sample is reported as 2370 nt.
- LNP disruption is performed with varying amounts of surfactant; surfactant levels and dilution ratios were tested in the method development.
Integration and operation
- The system is designed for robotic integration in high-throughput laboratories, sharing reagent kits with the 5300 platform.
- Method BE is referenced as an extended method in the application documentation.
- The data sheet and application notes do not provide electrical, interface, or environmental specifications in the supplied digests; those parameters must be taken from the full instrument manual.
Integration & Operating Notes
The instrument's sizing range is 2 to 6,000 nt; samples outside this window, such as the 11,000 nt IVT mRNA construct cited in the application note, require a method or kit validated for that size rather than direct extrapolation from the standard range.
The 5400 is built on the 5300 platform and is compatible with the same reagent kits; capillary arrays and kits from the Fragment Analyzer series must be matched to the method, and consumables are not part of the base instrument delivery.
Selection & Integration Q&A
Pick the 5400 when robotic integration and nine-plate capacity are required for unattended high-throughput runs. The 5200 and 5300 are lower-capacity siblings; the 5300 is quoted at 5 pg/µL sensitivity and the standard Fragment Analyzer handles three plates, so choose those when plate throughput and robot access are not limiting.
The 5400 is built on the 5300 platform and accepts the same reagent kits, so kits and capillary arrays must be ordered separately and matched to the method, such as the ZAG 135 or ZAG 110 dsDNA kits or the IVT mRNA/LNP method BE reagents; none are included in the base instrument.
LNP drug product must be disrupted with surfactant at a validated level and dilution ratio before injection; the application note tests varying surfactant amounts and dilution ratios, and sample sizing must stay within the 2–6,000 nt range or use a validated extended method for larger constructs.
Reagent kits, capillary arrays, surfactant reagents and robotic integration hardware are not part of the base instrument; the supplied digests do not specify service intervals, so maintenance scheduling and consumable replacement periods must be obtained from the full instrument manual.